Breast tomosynthesis may be a work-in-progress in the RSNA exhibit halls, but researchers are already considering ways to incorporate computer-assisted detection algorithms to improve its efficacy.
Breast tomosynthesis may be a work-in-progress in the RSNA exhibit halls, but researchers are already considering ways to incorporate computer-assisted detection algorithms to improve its efficacy.
Researchers from the University of Chicago and the University of Michigan presented papers Tuesday morning that evaluated several techniques for reconstructing suspected tumors from the multiple slices of tomographic acquisition or from the compiled volume data set. Both groups worked with the GE Digital Breast Tomosynthesis prototype developed by Dr. Daniel Kopans at Massachusetts General Hospital.
The Michigan researchers produced an area of 0.87 under the ROC curve with 80% sensitivity and two false positives per case, using a set of synthesized data. Looking only at projection views, the area under the ROC curve dropped to 0.82. Both were based on 26 cases with 23 masses, including 13 malignancies.
"We achieved fewer false positives with 3D views than with 2D, and the information fusion is more effective," said lead researcher Heang-Ping Chan, Ph.D.
Chicago researchers evaluated only projection views. A standard tomosynthesis scan involves 11 low-dose conebeam projections through the breast at 5-degree angles spread over an arc. The projections intersect with each other at various points and allow the software to confirm areas of suspected masses from more than one angle. For the Chicago trial, any region that was intersected by six or more projections was considered a positive finding. Among 21 cases of confirmed breast masses, the team achieved a sensitivity of 86%, but with six false positives per case.
In addition to projection views and reconstructed volumes, CAD could also be developed to look for suspicious findings across the 50 to 80 reconstructed image slices that could be produced for each set of breast data, the authors said.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
February 28th 2025In addition to contrast-enhanced mammography (CEM) demonstrating over a 90 percent detection rate for multifocal masses, researchers found that no significant difference between histological measurements and CEM, according to study findings presented at the European Congress of Radiology.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.